Neurocrine Biosciences, announced the appointment of Sanjay Keswani, M.D., to the company's executive management team as Chief Medical Officer (CMO) effective June 2, 2025. Dr. Keswani, an...
Geron Corporation, a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, announced the appointment of Joseph Eid, M.D....
